| Alanine, aspartate and glutamate metabolism |
2.15 |
0.00e+0 |
27/37 (72.97%) |
ASS1;GLUD1;GLUD2;...
|
| Arginine biosynthesis |
1.80 |
4.45e-2 |
17/22 (77.27%) |
ASS1;GLUD1;GLUD2;...
|
| Synthesis and degradation of ketone bodies |
1.77 |
4.22e-2 |
9/10 (90%) |
HMGCS1;ACAT1;HMGCS2
|
| Cytokine-cytokine receptor interaction |
-1.72 |
3.82e-2 |
246/295 (83.39%) |
IL33;TNF;IL17B;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.74 |
2.86e-2 |
62/70 (88.57%) |
ATP6V1B2;PTPRZ1;CDC42;...
|
| NOD-like receptor signaling pathway |
-1.74 |
3.11e-2 |
145/181 (80.11%) |
DNM1L;BCL2L1;ATG5;...
|
| IL-17 signaling pathway |
-1.80 |
1.14e-2 |
84/94 (89.36%) |
CASP3;TNF;IL17B;...
|
| Collecting duct acid secretion |
-1.80 |
1.18e-2 |
22/27 (81.48%) |
ATP6V1B2;ATP6V1C1;ATP6V1G1;...
|
| Legionellosis |
-1.88 |
3.55e-3 |
51/57 (89.47%) |
CASP3;TNF;BNIP3;...
|
| Amoebiasis |
-2.00 |
2.22e-3 |
99/102 (97.06%) |
SERPINB4;COL4A2;LAMB4;...
|
| Rheumatoid arthritis |
-2.00 |
2.96e-3 |
78/93 (83.87%) |
TNFRSF11A;IL6;ATP6V0C;...
|
| TNF signaling pathway |
-2.02 |
4.44e-3 |
103/112 (91.96%) |
CSF2;TNFRSF1B;CREB5;...
|
| Proteasome |
-2.21 |
0.00e+0 |
44/46 (95.65%) |
PSME2;PSMA2;PSMD1;...
|
